Intermittent Fasting: The Complete 2026 Guide
How to do intermittent fasting: the 16:8 protocol, what to drink, how to break your fast, and why GLP-1 makes it 3 times more effective.
Explore all articles about "glp-1": evidence-based insights, clinical studies, and GLP-1 peptide research. Updated content on GLP-1 Journal.
How to do intermittent fasting: the 16:8 protocol, what to drink, how to break your fast, and why GLP-1 makes it 3 times more effective.
Hepatic steatosis affects 1 in 3 Europeans. GLP-1 peptides reduce liver fat by up to 82%. Discover how TRIPLE-G acts on the liver.
Muscle loss during a GLP-1 protocol: what sarcopenia is, why it's the hidden risk of weight loss, and the 3 pillars to preserve lean mass.
Survodutide (dual GLP-1/glucagon agonist) vs retatrutide TRIPLE-G (triple agonist). Efficacy, mechanism, clinical data and results compared.
Retatrutide is a novel triple GIP/GLP-1/glucagon receptor agonist. Learn about its mechanism of action, clinical trial results, and weight loss potential.
A comprehensive guide to GLP-1 receptor agonist mechanisms: from the incretin effect to appetite suppression and delayed gastric emptying.
The incretin system explained: how GIP, GLP-1 and glucagon regulate metabolism, appetite and body weight. The science behind modern peptides.
Analysis of documented GLP-1 receptor agonist side effects: nausea, gastrointestinal effects, long-term safety data and management.
Comparison of the three leading GLP-1 peptides: semaglutide, tirzepatide and retatrutide. Mechanism, efficacy and development status.